Blood transfusion for acute decompensated heart failure—friend or foe?
Open Access
- 31 October 2009
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 158 (4), 653-658
- https://doi.org/10.1016/j.ahj.2009.08.001
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Anemia and Heart Failure: A Community StudyAmerican Journal Of Medicine, 2008
- Anemia and Mortality in Heart Failure PatientsJournal of the American College of Cardiology, 2008
- The prevalence of anemia in chronic heart failure and its impact on the clinical outcomesHeart Failure Reviews, 2008
- Heart failure and anemia: mechanisms and pathophysiologyHeart Failure Reviews, 2008
- Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and AnemiaCirculation, 2008
- Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndromeAmerican Heart Journal, 2007
- Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled TrialJournal of the American College of Cardiology, 2007
- Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart FailureCirculation, 2006
- The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyJournal of the American College of Cardiology, 2001
- The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsJournal of the American College of Cardiology, 2000